Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Endocrine Signaling01:45

Endocrine Signaling

53.5K
Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
53.5K
Endocrine Signaling01:45

Endocrine Signaling

5.7K
5.7K
Smooth Endoplasmic Reticulum01:21

Smooth Endoplasmic Reticulum

6.5K
Smooth endoplasmic reticulum or smooth ER is a sub-organelle with specialized functions in animal cells and plant cells. It is often associated with the tubule morphology of the endoplasmic reticulum.
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
6.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cancer detection rate of breast-MR in supplemental screening after negative mammography in women with dense breasts. Preliminary results of the MA-DETECT-Study after 200 participants.

European journal of radiology·2024
Same author

[The somewhat different cause of an obturation in stenosing terminal ileitis : Case report of a 39-year-old male patient with Crohn's disease].

Der Internist·2020
Same author

Continuous intraoperative neuromonitoring (cIONM) in head and neck surgery-a review.

HNO·2020
Same author

[Continuous intraoperative neuromonitoring (cIONM) in head and neck surgery-a review. German version].

HNO·2020
Same author

[Neuroendocrine tumors : Classification, clinical presentation and imaging].

Der Radiologe·2019
Same author

[Use of ultrasonography in the context of interventional pain therapy].

Schmerz (Berlin, Germany)·2018
Same journal

Der Radiologe·2024
Same journal

Der Radiologe·2024
Same journal

Der Radiologe·2024
Same journal

Der Radiologe·2024
Same journal

Der Radiologe·2022
Same journal

Der Radiologe·2022
See all related articles

Related Experiment Video

Updated: Apr 23, 2026

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

3.1K

[Multiple endocrine neoplasia (MEN)].

F Raue1, T Wilhelm

  • 1Endokrinologische, nuklearmedizinische Gemeinschaftspraxis Heidelberg, Brückenstr. 21, 9120, Heidelberg, Deutschland, friedhelm.raue@raue-endokrinologie.de.

Der Radiologe
|September 17, 2014
PubMed
Summary
This summary is machine-generated.

Early genetic screening and family testing can identify carriers of Multiple Endocrine Neoplasia (MEN) gene mutations. Timely diagnosis and treatment, including surgery and novel therapies like tyrosine kinase inhibitors (TKI), improve outcomes for MEN patients.

More Related Videos

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.7K

Related Experiment Videos

Last Updated: Apr 23, 2026

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

3.1K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.7K

Area of Science:

  • Genetics and Oncology
  • Hereditary Cancer Syndromes

Context:

  • Multiple Endocrine Neoplasia (MEN) types 1 and 2 are hereditary cancer syndromes characterized by diverse tumor types.
  • Genetic screening for MEN1 or RET mutations allows for early identification of at-risk individuals.

Purpose:

  • To outline diagnostic and therapeutic strategies for Multiple Endocrine Neoplasia (MEN) syndromes.
  • To highlight the importance of early detection and tailored treatment for improving patient outcomes.

Summary:

  • Early thyroidectomy is curative for medullary thyroid carcinoma (MTC) in MEN2. Tyrosine kinase inhibitors (TKI) offer new options for metastatic MTC.
  • Neuroendocrine tumors in MEN1 are managed surgically, with somatostatin or everolimus for progressive disease.
  • Imaging modalities like ultrasound, CT, and PET/CT are crucial for monitoring tumors and metastases in MEN patients.

Impact:

  • Effective management relies on specialized centers due to the complexity and rarity of MEN syndromes.
  • Monitoring tumor progression via imaging and tumor markers guides the initiation of systemic therapies, including TKIs.
  • Early diagnosis and intervention significantly enhance cure rates and patient prognosis in MEN.